| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1022418751 |
| P356 | DOI | 10.1007/S00005-015-0369-3 |
| P698 | PubMed publication ID | 26502273 |
| P50 | author | Dariusz Szukiewicz | Q59158896 |
| Marta Skoda | Q86558705 | ||
| P2093 | author name string | Anna Jarosz | |
| Ilona Dudek | |||
| P2860 | cites work | Behaviors of NIH-3T3 fibroblasts on graphene/carbon nanotubes: proliferation, focal adhesion, and gene transfection studies | Q42818980 |
| Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice | Q43665629 | ||
| Evidencing the mask effect of graphene oxide: a comparative study on primary human and murine phagocytic cells | Q43679997 | ||
| Nanobiotechnological approaches to delivery of DNA vaccine against fungal infection. | Q43905915 | ||
| Bending rigidity and Gaussian bending stiffness of single-layered graphene. | Q44293559 | ||
| Safety considerations for graphene: lessons learnt from carbon nanotubes. | Q45145718 | ||
| Graphene-based nanoplatelets: a new risk to the respiratory system as a consequence of their unusual aerodynamic properties. | Q45905009 | ||
| Determination of the local chemical structure of graphene oxide and reduced graphene oxide | Q46192295 | ||
| Interaction of substituted aromatic compounds with graphene | Q46216174 | ||
| Requirement of reactive oxygen species-dependent activation of ASK1-p38 MAPK pathway for extracellular ATP-induced apoptosis in macrophage. | Q46796816 | ||
| In vitro hemocompatibility and toxic mechanism of graphene oxide on human peripheral blood T lymphocytes and serum albumin | Q46817896 | ||
| In vivo biodistribution and toxicology of functionalized nano-graphene oxide in mice after oral and intraperitoneal administration | Q46883760 | ||
| A special issue on reviews in nanomedicine, drug delivery and vaccine development | Q48479700 | ||
| Preparation and characterization of graphene oxide paper. | Q50951359 | ||
| Evaluation of nanoparticle immunotoxicity. | Q51821021 | ||
| A special issue on reviews in biomedical applications of nanomaterials, tissue engineering, stem cells, bioimaging, and toxicity. | Q53230042 | ||
| Programmed cell death and apoptosis: origins of the theory. | Q53480462 | ||
| A carbon nanotube-polymer composite for T-cell therapy. | Q53482969 | ||
| Mechanical and histological evaluations of hydroxyapatite-coated and noncoated Ti6Al4V implants in tibia bone. | Q53893947 | ||
| Direct imaging of single-walled carbon nanotubes in cells. | Q54152431 | ||
| Effects of surface charges of graphene oxide on neuronal outgrowth and branching. | Q54692274 | ||
| A Response Calculus for Immobilized T Cell Receptor Ligands | Q56112100 | ||
| Ultrahigh electron mobility in suspended graphene | Q56430538 | ||
| Processable aqueous dispersions of graphene nanosheets | Q56508020 | ||
| Are carbon nanotubes safe? | Q56773829 | ||
| Chemical functionalization of graphene and its applications | Q58438870 | ||
| Graphene oxide, but not fullerenes, targets immunoproteasomes and suppresses antigen presentation by dendritic cells | Q23909717 | ||
| Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848 | Q24298297 | ||
| Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases | Q24632768 | ||
| Nanotoxicology | Q24676412 | ||
| Giant Intrinsic Carrier Mobilities in Graphene and Its Bilayer | Q27335986 | ||
| The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors | Q27860900 | ||
| Signal transduction by the JNK group of MAP kinases | Q28142592 | ||
| Apoptosis and cancer: mutations within caspase genes | Q28247775 | ||
| Superior thermal conductivity of single-layer graphene | Q28269187 | ||
| The rise of graphene | Q28290805 | ||
| Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis | Q28307738 | ||
| Graphene microsheets enter cells through spontaneous membrane penetration at edge asperities and corner sites | Q28386341 | ||
| Impact of carbon nanotubes and graphene on immune cells | Q28388540 | ||
| In vitro enhancement of dendritic cell-mediated anti-glioma immune response by graphene oxide | Q28389458 | ||
| Steering carbon nanotubes to scavenger receptor recognition by nanotube surface chemistry modification partially alleviates NFκB activation and reduces its immunotoxicity | Q28390421 | ||
| Minimizing oxidation and stable nanoscale dispersion improves the biocompatibility of graphene in the lung | Q28394834 | ||
| The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors | Q28512624 | ||
| Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation | Q29547369 | ||
| Mitochondrial membrane permeabilization in cell death | Q29547425 | ||
| The biochemistry of apoptosis | Q29547741 | ||
| Dose ranging, expanded acute toxicity and safety pharmacology studies for intravenously administered functionalized graphene nanoparticle formulations | Q30584400 | ||
| Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. | Q33217285 | ||
| Nano-Graphene Oxide for Cellular Imaging and Drug Delivery. | Q33710266 | ||
| In vitro comparison of the photothermal anticancer activity of graphene nanoparticles and carbon nanotubes | Q33744708 | ||
| Chitosan-functionalized graphene oxide as a nanocarrier for drug and gene delivery. | Q33888445 | ||
| T cell receptor binding kinetics required for T cell activation depend on the density of cognate ligand on the antigen-presenting cell. | Q33935247 | ||
| Crystal structure of human toll-like receptor 3 (TLR3) ectodomain | Q33987865 | ||
| Antibacterial activity of graphite, graphite oxide, graphene oxide, and reduced graphene oxide: membrane and oxidative stress | Q33995934 | ||
| Mitochondrial outer membrane permeabilization during apoptosis: the innocent bystander scenario | Q33995987 | ||
| Vaccination and herd immunity: what more do we know? | Q34273085 | ||
| Of mice and man: TLR11 (finally) finds profilin | Q34444339 | ||
| Mechanisms of TGF-beta-mediated apoptosis | Q34505463 | ||
| The biology of interleukin-2. | Q34585827 | ||
| The regulatory, inflammatory, and T cell programming roles of interleukin-2 (IL-2). | Q34591170 | ||
| Interferon-gamma: a historical perspective | Q34605180 | ||
| Biomedical applications of graphene and graphene oxide | Q34616764 | ||
| Spinning molecular immunology into successful immunotherapy | Q34632056 | ||
| Colloidal suspensions of highly reduced graphene oxide in a wide variety of organic solvents | Q34957793 | ||
| Chitosan nanoparticles act as an adjuvant to promote both Th1 and Th2 immune responses induced by ovalbumin in mice | Q35091726 | ||
| Anti-inflammatory effects of three-dimensional graphene foams cultured with microglial cells | Q35176123 | ||
| Adoptive-cell-transfer therapy for the treatment of patients with cancer | Q35210008 | ||
| Immunostimulatory oligonucleotides-loaded cationic graphene oxide with photothermally enhanced immunogenicity for photothermal/immune cancer therapy | Q35253976 | ||
| Transforming growth factor beta (TGFbeta)-induced apoptosis: the rise & fall of Bim | Q35320797 | ||
| Biological interactions of graphene-family nanomaterials: an interdisciplinary review | Q35675294 | ||
| Protective capacity of proteoliposomes from Mycobacterium bovis BCG in a mouse model of tuberculosis | Q35896225 | ||
| Recent advances in graphene family materials toxicity investigations | Q36454755 | ||
| Conservation and divergence in the transcriptional programs of the human and mouse immune systems | Q36637283 | ||
| Carbon nanotubes as nanomedicines: from toxicology to pharmacology | Q36657144 | ||
| Recent developments in the use of adenoviruses and immunotoxins in cancer gene therapy. | Q36811133 | ||
| Signaling to NF-kappaB by Toll-like receptors | Q37009320 | ||
| Graphene and graphene oxide: synthesis, properties, and applications | Q37779761 | ||
| Nanomedicine-nanoscale drugs and delivery systems | Q37814307 | ||
| Graphene in biomedicine: opportunities and challenges. | Q37850816 | ||
| Graphene and graphene oxide: biofunctionalization and applications in biotechnology | Q37852359 | ||
| Making carbon nanotubes biocompatible and biodegradable | Q37903284 | ||
| Medical applications of nanoparticles in biological imaging, cell labeling, antimicrobial agents, and anticancer nanodrugs | Q37922723 | ||
| Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy | Q37964608 | ||
| Biomedical applications of graphene | Q37997012 | ||
| Graphene: promises, facts, opportunities, and challenges in nanomedicine | Q38085753 | ||
| Prospects and challenges of graphene in biomedical applications | Q38089679 | ||
| Nanovaccines and their mode of action. | Q38102471 | ||
| Systematic review of economic evaluation analyses of available vaccines in Spain from 1990 to 2012. | Q38114267 | ||
| Nanomaterials in cancer-therapy drug delivery system | Q38117164 | ||
| Graphene-based materials biocompatibility: a review. | Q38117995 | ||
| Nanotoxicity of graphene and graphene oxide | Q38178290 | ||
| Immunotherapy applications of carbon nanotubes: from design to safe applications. | Q38196056 | ||
| Scale/topography of substrates surface resembling extracellular matrix for tissue engineering. | Q38209957 | ||
| A graphene platform for sensing biomolecules | Q38353721 | ||
| The inhibition of migration and invasion of cancer cells by graphene via the impairment of mitochondrial respiration. | Q38444045 | ||
| Surface-engineered graphene navigate divergent biological outcomes toward macrophages. | Q38908430 | ||
| Polycation stabilization of graphene suspensions | Q39004868 | ||
| The in vitro and in vivo toxicity of graphene quantum dots | Q39009972 | ||
| Graphene oxide induces toll-like receptor 4 (TLR4)-dependent necrosis in macrophages | Q39144108 | ||
| Functionalized carbon nanotubes as immunomodulator systems | Q39178999 | ||
| The interactions between pristine graphene and macrophages and the production of cytokines/chemokines via TLR- and NF-κB-related signaling pathways | Q39314767 | ||
| Simultaneous induction of autophagy and toll-like receptor signaling pathways by graphene oxide | Q39330324 | ||
| The role of the lateral dimension of graphene oxide in the regulation of cellular responses. | Q39387495 | ||
| Hemocompatibility and macrophage response of pristine and functionalized graphene | Q39396607 | ||
| The immunotoxicity of graphene oxides and the effect of PVP-coating | Q39438216 | ||
| The triggering of apoptosis in macrophages by pristine graphene through the MAPK and TGF-beta signaling pathways | Q39454636 | ||
| Three-dimensional graphene foam as a biocompatible and conductive scaffold for neural stem cells | Q39551101 | ||
| Intranasal immunization with poly(γ-glutamic acid) nanoparticles entrapping antigenic proteins can induce potent tumor immunity. | Q39576390 | ||
| In vitro toxicity evaluation of graphene oxide on A549 cells. | Q39624094 | ||
| The potential use of Echinacea in acne: control of Propionibacterium acnes growth and inflammation | Q39657299 | ||
| Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs | Q39759241 | ||
| B cell antigen receptor endocytosis and antigen presentation to T cells require Vav and dynamin. | Q39827413 | ||
| PEGylated nanographene oxide for delivery of water-insoluble cancer drugs | Q39956686 | ||
| Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials. | Q40091435 | ||
| Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. | Q40139914 | ||
| Effect of single wall carbon nanotubes on human HEK293 cells | Q40483465 | ||
| Ligand-regulated chimeric receptor approach reveals distinctive subcellular localization and signaling properties of the Toll-like receptors | Q40587520 | ||
| IRF3 mediates a TLR3/TLR4-specific antiviral gene program | Q40700858 | ||
| Synergistic activation of Toll-like receptor 8 by two RNA degradation products. | Q41504092 | ||
| Immunology: Toll-like receptors and antibody responses | Q42125203 | ||
| Graphene nanomesh | Q42150038 | ||
| Characterisation of Toll-like receptors 4, 5 and 7 and their genetic variation in the grey partridge. | Q42173563 | ||
| A systems toxicology approach to the surface functionality control of graphene-cell interactions | Q42256704 | ||
| P433 | issue | 3 | |
| P921 | main subject | graphene | Q169917 |
| P304 | page(s) | 195-215 | |
| P577 | publication date | 2015-10-26 | |
| P1433 | published in | Archivum Immunologiae et Therapiae Experimentalis | Q15760838 |
| P1476 | title | The Molecular Influence of Graphene and Graphene Oxide on the Immune System Under In Vitro and In Vivo Conditions | |
| P478 | volume | 64 |
| Q112579152 | Biocompatible Graphene Oxide Nanosheets Densely Functionalized with Biologically Active Molecules for Biosensing Applications |
| Q37649880 | Continuous release of bone morphogenetic protein-2 through nano-graphene oxide-based delivery influences the activation of the NF-κB signal transduction pathway |
| Q99711225 | Cytotoxicity and Immune Dysfunction of Dendritic Cells Caused by Graphene Oxide |
| Q42069275 | Graphene Oxide Nanosheets Stimulate Ruffling and Shedding of Mammalian Cell Plasma Membranes. |
| Q55331971 | Graphene-Based Nanomaterials for Tissue Engineering in the Dental Field. |
| Q57491731 | Immunomodulatory properties of graphene oxide for osteogenesis and angiogenesis |
| Q41226027 | The mechanisms of graphene-based materials-induced programmed cell death: a review of apoptosis, autophagy, and programmed necrosis |
Search more.